Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2006 1
2007 1
2008 1
2009 1
2010 1
2011 4
2012 1
2013 3
2014 1
2015 8
2016 5
2017 5
2018 8
2019 10
2020 11
2021 13
2022 14
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study.
Frane N, Stapleton E, Iturriaga C, Ganz M, Rasquinha V, Duarte R. Frane N, et al. J Cannabis Res. 2022 Aug 24;4(1):47. doi: 10.1186/s42238-022-00154-9. J Cannabis Res. 2022. PMID: 35999581 Free PMC article.
The purpose of this study was to explore patient perceived effects of cannabidiol on symptoms of arthritis. METHODS: A novel anonymous questionnaire was created to evaluate perceived efficacy of cannabidiol for the treatment of arthritis. ...Subgroup analysis by dia …
The purpose of this study was to explore patient perceived effects of cannabidiol on symptoms of arthritis. METHODS: A novel anonymou …
Immune Responses Regulated by Cannabidiol.
Nichols JM, Kaplan BLF. Nichols JM, et al. Cannabis Cannabinoid Res. 2020 Feb 27;5(1):12-31. doi: 10.1089/can.2018.0073. eCollection 2020 Mar 1. Cannabis Cannabinoid Res. 2020. PMID: 32322673 Free PMC article. Review.
Introduction: Cannabidiol (CBD) as Epidiolex() (GW Pharmaceuticals) was recently approved by the U.S. ...The review then provides a summary of in vivo and in vitro effects in the immune system, in autoimmune models, with a focus on experimental autoimmune enc …
Introduction: Cannabidiol (CBD) as Epidiolex() (GW Pharmaceuticals) was recently approved by the U.S. ...The review then provides a s …
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies.
Luz-Veiga M, Azevedo-Silva J, Fernandes JC. Luz-Veiga M, et al. Pharmaceuticals (Basel). 2023 Jan 20;16(2):155. doi: 10.3390/ph16020155. Pharmaceuticals (Basel). 2023. PMID: 37259306 Free PMC article. Review.
The phytocannabinoid cannabidiol (CBD) is receiving increasing attention due to its pharmacological properties. ...In this review, we take a closer look at the molecular mechanisms of CBD and its potential therapeutic application in the context of cancer, neurodegeneration …
The phytocannabinoid cannabidiol (CBD) is receiving increasing attention due to its pharmacological properties. ...In this review, we …
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance.
Martini S, Gemma A, Ferrari M, Cosentino M, Marino F. Martini S, et al. Int J Mol Sci. 2023 Feb 4;24(4):3125. doi: 10.3390/ijms24043125. Int J Mol Sci. 2023. PMID: 36834537 Free PMC article. Review.
Cannabidiol (CBD) is the main non-psychotropic cannabinoid derived from cannabis (Cannabis sativa L., fam. ...Clinical studies are now warranted to establish the therapeutic role of CBD in diseases with a strong inflammatory component, such as multiple sclerosis and other
Cannabidiol (CBD) is the main non-psychotropic cannabinoid derived from cannabis (Cannabis sativa L., fam. ...Clinical studies are no
Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
Elliott DM, Singh N, Nagarkatti M, Nagarkatti PS. Elliott DM, et al. Front Immunol. 2018 Aug 3;9:1782. doi: 10.3389/fimmu.2018.01782. eCollection 2018. Front Immunol. 2018. PMID: 30123217 Free PMC article.
Multiple sclerosis (MS) is a chronic debilitating autoimmune disease without a cure. While the use of marijuana cannabinoids for MS has recently been approved in some countries, the precise mechanism of action leading to attenuate neuroinflammation is not clear. We used ex …
Multiple sclerosis (MS) is a chronic debilitating autoimmune disease without a cure. While the use of marijuana cannabinoids for MS h …
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI, Nguyen LC, Oumeslakht L, Bensussan A, Ben Mkaddem S. Aziz AI, et al. Cannabis Cannabinoid Res. 2023 Apr;8(2):254-269. doi: 10.1089/can.2022.0133. Epub 2022 Nov 22. Cannabis Cannabinoid Res. 2023. PMID: 36413346 Review.
Introduction: Cannabidiol (CBD) is the second most abundant Phytocannabinoid in Cannabis extracts. ...Conclusion: The presented evidence suggests that the endocannabinoid system is a prominent target for the treatment of inflammatory and autoimmune diseases, rheumat …
Introduction: Cannabidiol (CBD) is the second most abundant Phytocannabinoid in Cannabis extracts. ...Conclusion: The presented evide …
Phytocannabinoids in the Pharmacotherapy of Psoriasis.
Wroński A, Jarocka-Karpowicz I, Stasiewicz A, Skrzydlewska E. Wroński A, et al. Molecules. 2023 Jan 25;28(3):1192. doi: 10.3390/molecules28031192. Molecules. 2023. PMID: 36770858 Free PMC article. Review.
Due to the modification of the redox balance and inflammation, phytocannabinoids are used in the treatment of various diseases, including autoimmune dermatoses, such as atopic dermatitis and psoriasis. Psoriasis is one of the most common dermatoses, and one of unknown etio …
Due to the modification of the redox balance and inflammation, phytocannabinoids are used in the treatment of various diseases, including …
Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation.
Lee WS, Erdelyi K, Matyas C, Mukhopadhyay P, Varga ZV, Liaudet L, Haskú G, Čiháková D, Mechoulam R, Pacher P. Lee WS, et al. Mol Med. 2016 Sep;22:136-146. doi: 10.2119/molmed.2016.00007. Epub 2016 Jan 8. Mol Med. 2016. PMID: 26772776 Free PMC article.
Conventional immunosuppressive therapies often provide unsatisfactory results and are associated with adverse toxicities during the treatment of autoimmune myocarditis. Cannabidiol (CBD) is a nonpsychoactive constituent of marijuana that exerts antiinflammatory effe …
Conventional immunosuppressive therapies often provide unsatisfactory results and are associated with adverse toxicities during the treatmen …
Cannabidiol (CBD) Consumption and Perceived Impact on Extrahepatic Symptoms in Patients with Autoimmune Hepatitis.
Mathur K, Vuppalanchi V, Gelow K, Vuppalanchi R, Lammert C. Mathur K, et al. Dig Dis Sci. 2020 Jan;65(1):322-328. doi: 10.1007/s10620-019-05756-7. Epub 2019 Jul 30. Dig Dis Sci. 2020. PMID: 31363952 Free PMC article.
BACKGROUND AND AIMS: Utilization and safety of cannabidiol (CBD) in patients with autoimmune hepatitis (AIH) are currently unknown. ...METHODS: An invitation to complete a CBD-specific questionnaire was posted every other day to well-established autoimmune he …
BACKGROUND AND AIMS: Utilization and safety of cannabidiol (CBD) in patients with autoimmune hepatitis (AIH) are currently unk …
Beyond THC and Endocannabinoids.
Pacher P, Kogan NM, Mechoulam R. Pacher P, et al. Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:637-659. doi: 10.1146/annurev-pharmtox-010818-021441. Epub 2019 Oct 3. Annu Rev Pharmacol Toxicol. 2020. PMID: 31580774 Review.
Numerous endocannabinoid-like compounds have been discovered. The Cannabis plant constituent cannabidiol (CBD) was found to exert beneficial effects in many preclinical disease models ranging from epilepsy, cardiovascular disease, inflammation, and autoimmunity to n …
Numerous endocannabinoid-like compounds have been discovered. The Cannabis plant constituent cannabidiol (CBD) was found to exert ben …
92 results